Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dermatological Medicine
Volume 2014, Article ID 452720, 3 pages
http://dx.doi.org/10.1155/2014/452720
Case Report

Acquired Brachial Cutaneous Dyschromatosis in a 60-Year-Old Male: A Case Report and Review of the Literature

Department of Dermatology, Jefferson Medical College, Thomas Jefferson University, 833 Chestnut Street, Suite 740, Philadelphia, PA 19107, USA

Received 1 July 2014; Accepted 17 December 2014; Published 31 December 2014

Academic Editor: Alireza Firooz

Copyright © 2014 Nadia Abidi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Rongioletti and A. Rebora, “Acquired brachial cutaneous dyschromatosis: a common pigmentary disorder of the arm in middle-aged women,” Journal of the American Academy of Dermatology, vol. 42, no. 4, pp. 680–684, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. S. W. Hu, J. Chu, S. Meehan, H. Kamino, and M. K. Pomeranz, “Acquired brachial cutaneous dyschromatosis,” Dermatology Online Journal, vol. 17, no. 10, article 16, 2011, http://escholarship.org/uc/item/09r7454f. View at Google Scholar
  3. D. Lipsker, “What is poikiloderma?” Dermatology, vol. 207, no. 3, pp. 243–245, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. E. Vega, L. Waxtein, R. Arenas, M. T. Hojyo, and L. Dominguez-Soto, “Ashy dermatosis versus lichen planus pigmentosus: a controversial matter,” International Journal of Dermatology, vol. 31, no. 2, pp. 87–88, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. T. F. Cestari, L. P. Dantas, and J. C. Boza, “Acquired hyperpigmentations,” Anais Brasileiros de Dermatologia, vol. 89, no. 1, pp. 11–25, 2014. View at Publisher · View at Google Scholar
  6. L. D. Soto, M. E. V. Memije, R. Arenas, and L. W. Morgenstein, “Dermatosis cinecienta. A clinico-pathological study of 20 patients (1989–1990),” Gaceta Médica de México, vol. 128, no. 6, pp. 623–628, 1992. View at Google Scholar · View at Scopus
  7. D. Dereure, “Drug-induced skin pigmentation,” American Journal of Clinical Dermatology, vol. 2, no. 4, pp. 253–262, 2001. View at Publisher · View at Google Scholar
  8. O. Dereure, “Drug-induced skin pigmentation epidemiology, diagnosis and treatment,” The American Journal of Clinical Dermatology, vol. 2, no. 4, pp. 253–262, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. U. M. Steckelings, M. Artuc, T. Wollschläger, S. Wiehstutz, and B. M. Henz, “Angiotensin-converting enzyme inhibitors as inducers of adverse cutaneous reactions,” Acta Dermato-Venereologica, vol. 81, no. 5, pp. 321–325, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Picardo and M. Carrera, “New and experimental treatments of cloasma and other hypermelanoses,” Dermatologic Clinics, vol. 25, no. 3, pp. 353–362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. E. P. Tierney and C. W. Hanke, “Review of the literature: treatment of dyspigmentation with fractionated resurfacing,” Dermatologic Surgery, vol. 36, no. 10, pp. 1499–1508, 2010. View at Publisher · View at Google Scholar · View at Scopus